Zeaxanthin inhibits hypoxia-induced VEGF secretion by RPE cells through decreased protein levels of hypoxia-inducible factors-1 α

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Rosen, Richard ^a,b   Vagaggini, Tommaso ^a   Chen, Yueqin ^a   Hu, Dan Ning ^a,b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT CHLORIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; ZEAXANTHIN; ANTIOXIDANT; COBALT; MESSENGER RNA; OXYGEN; VASCULOTROPIN A;

ADULT; ARTICLE; CELL HYPOXIA; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; ELISA KIT; HUMAN; HUMAN CELL; IN VITRO STUDY; MIDDLE AGED; OXYGEN TENSION; PRIMARY CELL CULTURE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RETINA PIGMENT CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PHYSIOLOGY; RETINAL PIGMENT EPITHELIUM;

ANTIOXIDANTS; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; COBALT; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIDDLE AGED; OXYGEN; RETINAL PIGMENT EPITHELIUM; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZEAXANTHINS;

EID: 84922352574     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/687386     Document Type: Article

References (70)

1. R. M. B. Loureiro and P. A. D'Amore, "Transcriptional regulation of vascular endothelial growth factor in cancer", Cytokine & Growth Factor Reviews, vol. 16, no. 1, pp. 77-89, 2005.
2. K. Xie, D. Wei, Q. Shi, and S. Huang, "Constitutiveand inducible expression and regulation of vascular endothelial growth factor", Cytokine and Growth Factor Reviews, vol. 15, no. 5, pp. 297-324, 2004.
3. C. J. Pournaras, J. W. Miller, E. S. Gragoudas et al., "Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina", Archives of Ophthalmology, vol. 115, no. 12, pp. 1553-1558, 1997.
4. A. N. Witmer, G. F. J. M. Vrensen, C. J. F. Van Noorden, and R. O. Schlingemann, "Vascular endothelial growth factors and angiogenesis in eye disease", Progress in Retinal and Eye Research, vol. 22, no. 1, pp. 1-29, 2003.
5. O. Arjamaa, M. Nikinmaa, A. Salminen, and K. Kaarniranta, "Regulatory role of HIF-1a in the pathogenesis of age-related macular degeneration (AMD)", Ageing Research Reviews, vol. 8, no. 4, pp. 349-358, 2009.
6. J. S. Penn, A. Madan, R. B. Caldwell, M. Bartoli, R. W. Caldwell, and M. E. Hartnett, "Vascular endothelial growth factor in eye disease", Progress in Retinal and Eye Research, vol. 27, no. 4, pp. 331-371, 2008.
7. J. W. Miller, A. P. Adamis, D. T. Shima et al., "Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model", The American Journal of Pathology, vol. 145, no. 3, pp. 574-584, 1994.
8. N. Okamoto, T. Tobe, S. F. Hackett et al., "Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization", The American Journal of Pathology, vol. 151, no. 1, pp. 281-291, 1997.
9. I. A. Pierce, R. L. Avery, E. D. Foley, L. P. Aiello, and L. E. H. Smith, "Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization", Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 3, pp. 905-909, 1995.
10. H. Wang, P. Geisen, E. S. Wittchen et al., "The role of RPE cell-associated VEGF189 in choroidal endothelial cell transmigration across the RPE", Investigative Ophthalmology and Visual Science, vol. 52, no. 1, pp. 570-578, 2011.
11. C. F. Bento, R. Fernandes, P. Matafome, C. Sena, R. Seia, and P. Pereira, "Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction", Experimental Physiology, vol. 95, no. 9, pp. 955-970, 2010.
12. W.-C. Wu, Y.-H. Kao, P.-S. Hu, and J.-H. Chen, "Geldanamycin, a HSP90 inhibitor, attenuates the hypoxia-induced vascular endothelial growth factor expression in retinal pigment epithelium cells in vitro", Experimental Eye Research, vol. 85, no. 5, pp. 721-731, 2007.
13. P. Geisen, J. R. McColm, B. M. King, and M. E. Hartnett, "Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture", Current Eye Research, vol. 31, no. 9, pp. 739-748, 2006.
14. N. Ghiso, R. M. Rohan, S. Amano, R. Garland, and A. P. Adamis, "Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP", Investigative Ophthalmology & Visual Science, vol. 40, no. 6, pp. 1033-1039, 1999.
15. H. G. T. Blaauwgeers, G. M. Holtkamp, H. Rutten et al., "Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris: evidence for a trophic paracrine relation", The American Journal of Pathology, vol. 155, no. 2, pp. 421-428, 1999.
16. K. B. Cullberg, J. Olholm, S. K. Paulsen et al., "Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro", European Journal of Pharmaceutical Sciences, vol. 49, no. 2, pp. 251-257, 2013.
17. F. Forooghian, R. Razavi, and L. Timms, "Hypoxia-inducible factor expression in human RPE cells", British Journal of Ophthalmology, vol. 91, no. 10, pp. 1406-1410, 2007.
18. C. H. Lin, C. H. Li, P. L. Liao et al., "Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxiadependent manner through the PI-3 kinase/Akt/mTOR pathway", British Journal of Pharmacology, vol. 168, no. 4, pp. 920-931, 2013.
19. P. Zhang, X. Zhang, X. Hao et al., "Rac1 activates HIF-1 in retinal pigment epithelium cells under hypoxia", Graefes Archive for Clinical and Experimental Ophthalmology, vol. 247, no. 5, pp. 633-639, 2009.
20. J. Zhu, Y.-S. Wang, J. Zhang et al., "Focal adhesion kinase signaling pathway participates in the formation of choroidal neovascularization and regulates the proliferation and migration of choroidal microvascular endothelial cells by acting through HIF-1 and VEGF expression in RPE cells", Experimental Eye Research, vol. 88, no. 5, pp. 910-918, 2009.
21. Q. Xiao, S. Zeng, M. Lv, and S. Ling, "Small hairpin loop RNA targeting HIF-1a down-regulates VEGF and up-regulates PEDF in human retinal pigment epithelial cells under hypoxic condition", Journal of Huazhong University of Science and Technology-Medical Science, vol. 28, no. 4, pp. 460-464, 2008.
22. Q. Xiao, S. Zeng, S. Ling, and M. Lv, "Up-regulation of HIF-1a and VEGF expression by elevated glucose concentration and hypoxia in cultured human retinal pigment epithelial cells", Journal of Huazhong University of Science and Technology, vol. 26, no. 4, pp. 463-465, 2006.
23. M.-C. Chen, C.-F. Lee, W.-H. Huang, and T.-C. Chou, "Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1a/VEGF signaling pathway in human bladder cancer cells", Biochemical Pharmacology, vol. 85, no. 9, pp. 1278-1287, 2013.
24. H. Z. Imtiyaz and M. C. Simon, "Hypoxia-inducible factors as essential regulators of inflammation", Current Topics in Microbiology and Immunology, vol. 345, no. 1, pp. 105-120, 2010.
25. M. C. Brihimi-Horn and J. Pouyssegur, "HIF at a glance", Journal of Cell Science, vol. 122, no. 8, pp. 1055-1057, 2009.
26. A. Weidemann and R. S. Johnson, "Biology of HIF-1a", Cell Death & Differentiation, vol. 15, no. 4, pp. 621-627, 2008.
27. O. Sommerburg, J. E. E. Keunen, A. C. Bird, and F. J. G. M. Van Kuijk, "Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes", British Journal of Ophthalmology, vol. 82, no. 8, pp. 907-910, 1998.
28. R. Vishwanathan, M. Neuringer, D. Max Snodderly, W. Schalch, and E. J. Johnson, "Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates", Nutritional Neuroscience, vol. 16, no. 1, pp. 21-29, 2013.
29. E. J. Johnson, M. Neuringer, R. M. Russell, W. Schalch, and D. M. Snodderly, "Nutritional manipulation of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys", Investigative Ophthalmology and Visual Science, vol. 46, no. 2, pp. 692-702, 2005.
30. P. S. Bernstein, F. Khachik, L. S. Carvalho, G. J. Muir, D.-Y. Zhao, and N. B. Katz, "Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye", Experimental Eye Research, vol. 72, no. 3, pp. 215-223, 2001.
31. D. M. Snodderly, G. J. Handelman, and A. J. Adler, "Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys", Investigative Ophthalmology& Visual Science, vol. 32, no. 2, pp. 268-279, 1991.
32. S. S. Ahmed, M. N. Lott, and D. M. Marcus, "The macular xanthophylls", Survey of Ophthalmology, vol. 50, no. 2, pp. 183-193, 2005.
33. J. M. Seddon, U. A. Ajani, R. D. Sperduto et al., "Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration", The Journal of the American Medical Association, vol. 272, no. 18, pp. 1413-1420, 1994.
34. J. S. L. Tan, J. J. Wang, V. Flood, E. Rochtchina, W. Smith, and P. Mitchell, "Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study", Ophthalmology, vol. 115, no. 2, pp. 334-341, 2008.
35. J. P. San Giovanni, E. Y. Chew, T. E. Clemons et al., "The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report No. 22", Archives of Ophthalmology, vol. 125, no. 9, pp. 1225-1232, 2007.
36. T. Michikawa, S. Ishida, Y. Nishiwaki et al., "Serum antioxidants and age-related macular degeneration among older Japanese", Asia Pacific Journal of Clinical Nutrition, vol. 18, no. 1, pp. 1-7, 2009.
37. S. Beatty, U. Chakravarthy, J. M. Nolan et al., "Secondary outcomes in a clinical trial of Carotenoids with Coantioxidants versus placebo in early age-related macular degeneration", Ophthalmology, vol. 120, no. 3, pp. 600-606, 2013.
38. L. Ho, R. Van Leeuwen, J. C. M. Witteman et al., "Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and a>-3 fatty acids: the Rotterdam Study", Archives of Ophthalmology, vol. 129, no. 6, pp. 758-766, 2011.
39. F. M. Barker II, "Dietary supplementation: effects on visual performance and occurrence of AMD and cataracts", Current Medical Research and Opinion, vol. 26, no. 8, pp. 2011-2023, 2010.
40. The Age-Related Eye Disease Study 2 (AREDS2) Research Group, "Lutein + zeaxanthin and omega-3 fatty acids for agerelated macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial", The Journal of the American Medical Association, vol. 309, no. 19, pp. 2005-2015, 2013.
41. L. Ma, H.-L. Dou, Y.-Q. Wu et al., "Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis", British Journal of Nutrition, vol. 107, no. 3, pp. 350-359, 2012.
42. Q. Bian, S. Gao, J. Zhou et al., "Luteinandzeaxanthinsupplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells", Free Radical Biology and Medicine, vol. 53, no. 6, pp. 1298-1307, 2012.
43. P. Bhosale, B. Serban, Y. Z. Da, and P. S. Bernstein, "Identification and metabolic transformations of carotenoids in ocular tissues of the Japanese quail Coturnix japonica", Biochemistry, vol. 46, no. 31, pp. 9050-9057, 2007.
44. S. R. Kim, K. Nakanishi, Y. Itagaki, and J. R. Sparrow, "Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin", Experimental Eye Research, vol. 82, no. 5, pp. 828-839, 2006.
45. S. E. G. Nilsson, S. P. Sundelin, U. Wihlmark, and U. T. Brunk, "Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage", Documenta Ophthalmologica, vol. 106, no. 1, pp. 13-16, 2003.
46. A. J. Chucair, N. P. Rotstein, J. P. San Giovanni, A. During, E. Y. Chew, and L. E. Politi, "Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid", Investigative Ophthalmology and Visual Science, vol. 48, no. 11, pp. 5168-5177, 2007.
47. E. Loane, J. M. Nolan, O. O'Donovan, P. Bhosale, P. S. Bernstein, and S. Beatty, "Transport andretinal captureofluteinand zeaxanthin with reference to age-related macular degeneration", Survey of Ophthalmology, vol. 53, no. 1, pp. 68-81, 2008.
48. T. Tanaka, M. Shnimizu, and H. Moriwaki, "Cancer chemoprevention by carotenoids", Molecules, vol. 17, no. 3, pp. 3202-3242, 2012.
49. R. A. Kowluru, B. Menon, and D. L. Gierhart, "Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats", Investigative Ophthalmology & Visual Science, vol. 49, no. 4, pp. 1645-1651, 2008.
50. P. Fernandez-Robredo, S. Recalde, G. Anwiz et al., "Effect of zeaxanthin and antioxidant supplementation on vascular endothelial growth factor (VEGF) expression in apolipoprotein-e deficient mice", Current Eye Research, vol. 34, no. 7, pp. 543-552, 2009.
51. A. Kijlstra, Y. Tian, E. R. Kelly, and T. T. J. M. Berendschot, "Lutein: More than just a filter for blue light", Progress in Retinal and Eye Research, vol. 31, no. 4, pp. 303-315, 2012.
52. D.-N. Hu, H. E. Savage, and J. E. Roberts, "Uveal melanocytes, ocular pigment epithelium, and Muller cells in culture: in vitro toxicology", International Journal of Toxicology, vol. 21, no. 6, pp. 465-472, 2002.
53. W.-C. Wu, D.-N. Hu, H.-X. Gao et al., "Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells", Molecular Vision, vol. 16, pp. 1864-1873, 2010.
54. D.-N. Hu, S. A. McCormick, R. Ritch, and K. Pelton-Henrion, "Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes", Investigative Ophthalmology & Visual Science, vol. 34, no. 7, pp. 2210-2219, 1993.
55. X. Dong, Y.-S. Wang, G.-R. Dou et al., "Influence of dll4 via hif-1a-vegf signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions", PLoS ONE, vol. 6, no. 4, Article ID e18481, 2011.
56. L. Notari, A. Miller, A. Martínez et al., "Pigment epitheliumderived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia", Investigative Ophthalmology and Visual Science, vol. 46, no. 8, pp. 2736-2747, 2005.
57. B. Wang, Y. Zou, Z.-L. Yuan, and J.-G. Xiao, "Genistein suppressed upregulation of vascular endothelial growth factor expression by cobalt chloride and hypoxia in rabbit retinal pigment epithelium cells", Journal of Ocular Pharmacologyand Therapeutics, vol. 19, no. 5, pp. 457-464, 2003.
58. Z. Cui, E. Song, D.-N. Hu, M. Chen, R. Rosen, and S. A. McCormick, "Butein induces apoptosis in human uveal melanoma cells through mitochondrial apoptosis pathway", Current Eye Research, vol. 37, no. 8, pp. 730-739, 2012.
59. Z. Zhang, J. Yan, Y. Chang, S. Shi Du Yan, and H. Shi, "Hypoxia inducible factor-1 as a target for neurodegenerative diseases", Current Medicinal Chemistry, vol. 18, no. 28, pp. 4335-4343, 2011.
60. J.-H. Oh, A. Togloom, S.-W. Kim, and K. Huh, "Effects of ginkgo biloba extract on cultured human retinal pigment epithelial cells under chemical hypoxia", Current Eye Research, vol. 38, no. 10, pp. 1072-1082, 2013.
61. M. M. Sanz, L. E. Johnson, S. Ahuja, P. A. R. Ekstrom, J. Romero, and T. Van Veen, "Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration", Neuroscience, vol. 145, no. 3, pp. 1120-1129, 2007.
62. R. J. Olk, E. Peralta, S. Sayegh, and D. L. Gierhart, "Does Oral zeaxanthin improve the anatomic and visual outcome of triple therapy for subfoveal choroidal CNV in age related macular degeneration (ARMD)", in Proceedings of the 44th Retina Society Meeting, Poster no. 17, Rome, Italy, 2011.
63. K. Manousaridis and J. Talks, "Macular ischaemia: a contraindication for anti-VEGF treatment in retinal vascular disease?" British Journal of Ophthalmology, vol. 96, no. 2, pp. 179-184, 2012.
64. A. M. Carneiro, R. Costa, M. S. Falcao et al., "Vascular endothelial growth factor plasma levels before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumab", Acta Ophthalmologica, vol. 90, no. 1, pp. e25-e30, 2012.
65. F. Semeraro, F. Morescalchi, F. Parmeggiani, B. Arcidiacono, and C. Costagliola, "Systemic adverse drug reactions secondary to anti-VEGF intravitreal injection in patients with neovascular age-related macular degeneration", Current Vascular Pharmacology, vol. 9, no. 5, pp. 629-646, 2011.
66. J. Christoforidis, R. Ricketts, C. Pratt et al., "The effect of intravitreal anti-VEGF agents on peripheral wound healing in arabbitmodel", Clinical Ophthalmology, vol. 6, no. 1, pp. 61-69, 2012.
67. H. R. Rezvani, N. Ali, L. J. Nissen et al., "HIF-1a in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and noncancer disorders", Journal of Investigative Dermatology, vol. 131, no. 9, pp. 1793-1805, 2011.
68. R. Nuzzi and F. Tridico, "Local and systemic complications after intravitreal administration of anti-vascular endothelial growth factor agents in the treatment of different ocular diseases: a fiveyear retrospective study", Seminars in Ophthalmology, 2013.
69. S. Day, K. Acquah, P. Mruthyunjaya, D. S. Grossman, P. P. Lee, and F. A. Sloan, "Ocular complicationsafterantivascular endothelial growth factor therapy in medicare patients with age-related macular degeneration", The American Journal of Ophthalmology, vol. 152, no. 2, pp. 266-272, 2011.
70. D. Y. Choi, M. C. Ortube, C. A. McCannel et al., "Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib", Retina, vol. 31, no. 6, pp. 1028-1035, 2011.